Compounds > meglumine

meglumine and AIDS Seroconversion

meglumine has been researched along with AIDS Seroconversion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amari, L; Belhaj, S; Ben Chaabene, T; Goubontini, A; Kilani, B1
Aguado, JM; Costa, JR; López-Medrano, F; Rodriguez-Peralto, JL1

Other Studies

2 other study(ies) available for meglumine and AIDS Seroconversion

ArticleYear
[Relapse of visceral leishmaniasis in HIV infection. Benefit of amphotericin B].
    La Tunisie medicale, 2004, Volume: 82, Issue:3

    Topics: Adult; Amphotericin B; Antiprotozoal Agents; Follow-Up Studies; HIV Seropositivity; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Time Factors

2004
An HIV-positive man with tattoo induration.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jul-15, Volume: 45, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immunohistochemistry; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Risk Assessment; Tattooing

2007